SCHEMBL1666706

SCHEMBL1666706

O=Cc1ccc(-c2ccc(-c3ccc(C=O)cc3)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 4/20 0.58
HSD17B10 Q99714 1/20 0.58
ALDH5A1 P51649 1/20 0.58
ABAT P80404 1/20 0.58
DRD1 P21728 2/20 0.56
ALDH1A1 P00352 6/20 0.56
TYR P14679 1/20 0.50
KIF11 P52732 1/20 0.50
KDM4E B2RXH2 1/20 0.50
CYP2A13 Q16696 1/20 0.50
ALDH1A3 P47895 2/20 0.46
ALDH3A1 P30838 1/20 0.46
BRD4 O60885 1/20 0.45
EGFR P00533 1/20 0.44
TRIM24 O15164 1/20 0.44
TRIM33 Q9UPN9 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25288128 1.00 CYP2A6 (0.58) CYP2A6HSD17B10ALDH5A1ABATDRD1
SCHEMBL976904 1.00 CYP2A6 (0.58) CYP2A6HSD17B10ALDH5A1ABATDRD1
Hydrochloric Acid SCHEMBL7799271 0.97 CYP2A6 (0.55) CYP2A6HSD17B10ALDH5A1ABATDRD1
Hydrogen Sulfide SCHEMBL21407995 0.97 CYP2A6 (0.55) CYP2A6HSD17B10ALDH5A1ABATDRD1
Hydrochloric Acid SCHEMBL11476850 0.97 CYP2A6 (0.55) CYP2A6HSD17B10ALDH5A1ABATDRD1
SCHEMBL4096252 0.91 CYP2A6 (0.50) CYP2A6HSD17B10ALDH5A1ABATDRD1
SCHEMBL5711166 0.91 CYP2A6 (0.55) CYP2A6HSD17B10ALDH5A1ABATDRD1
SCHEMBL25249571 0.91 CYP2A6 (0.50) CYP2A6HSD17B10ALDH5A1ABATDRD1
SCHEMBL31171 0.89 CYP2A6 (0.69) CYP2A6HSD17B10ALDH5A1ABATALDH1A1
SCHEMBL4956384 0.89 CYP2A6 (0.69) CYP2A6HSD17B10ALDH5A1ABATALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4686720-A1 SYNTHESIS OF ORGANIC MACROCYCLES THROUGH CLIP-OFF CHEMISTRY Fundació Institut Català de Nanociència i Nanotecnologia (ICN2) (ES) 2026-02-04 EP claimed
CN-119139943-A Triazine covalent organic framework film and preparation method and application thereof 天津大学浙江研究院 2024-12-17 CN claimed
CN-116120505-B Halogen-containing pyrenyl covalent organic framework polymer photocatalyst, and preparation method and application thereof 福州大学 2024-08-20 CN claimed
CN-118359779-A Sp derived from carbonyl monomer2Carbon conjugated polymer and preparation method and application thereof 中国科学院宁波材料技术与工程研究所 2024-07-19 CN claimed
CN-117624520-A Trifluoromethyl modified pyrenyl covalent organic framework material, and preparation method and application thereof 中国石油大学(华东) 2024-03-01 CN claimed
WO-2023124952-A1 GREEN SOLID-PHASE SYNTHESIS METHOD FOR COVALENT ORGANIC FRAMEWORK MATERIAL 张振杰 2023-07-06 WO claimed
CN-116120505-A Halogen-containing pyrenyl covalent organic framework polymer photocatalyst, and preparation method and application thereof 福州大学 2023-05-16 CN claimed
CN-114773556-A Green solid-phase synthesis method of covalent organic framework material 南开大学 2022-07-22 CN claimed
CN-114409862-A 2,4, 6-trimethylpyridine-based vinyl-bridged two-dimensional covalent organic framework material and preparation method thereof 上海交通大学 2022-04-29 CN claimed
EP-4686720-A1 SYNTHESIS OF ORGANIC MACROCYCLES THROUGH CLIP-OFF CHEMISTRY Fundació Institut Català de Nanociència i Nanotecnologia (ICN2) (ES) 2026-02-04 EP disclosed
US-20260028317-A1 EFFICIENT PROCEDURE FOR THE SYNTHESIS OF HYDRAZONE-LINKED TETRAHEDRAL NANOCAGES UNIV VERMONT (US) 2026-01-29 US disclosed
US-12492331-B2 Composite material including COF, heat dissipation/storage member, and method for producing said composite material, and COF single crystal and production method therefor JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2025-12-09 US disclosed
CN-119320483-A Macroscopic quantity preparation of covalent organic framework material based on ligustrazine and application of adsorption and separation of low-chain hydrocarbon VOCs gas 南开大学 2025-01-17 CN disclosed
CN-119139943-A Triazine covalent organic framework film and preparation method and application thereof 天津大学浙江研究院 2024-12-17 CN disclosed
US-20130004896-A1 COMPOUND FOR RESIST AND RADIATION-SENSITIVE COMPOSITION SPECIFICATION ECHIGO MASATOSHI (JP) 2013-01-03 US disclosed
US-20110165516-A1 COMPOUND FOR RESIST AND RADIATION-SENSITIVE COMPOSITION ECHIGO MASATOSHI 2011-07-07 US disclosed
US-7919223-B2 Polyphenol compound synthesized by condensation between aromatic ketone or aldehyde and a phenol; acid-amplified, non-polymeric resist; highly sensitive to KrF excimer lasers, extreme ultraviolet rays, electron beams, X-rays; resist patterns with high resolution, high heat, etch resistance MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2011-04-05 US disclosed
US-20080113294-A1 Compound for Resist and Radiation-Sensitive Composition MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2008-05-15 US disclosed
EP-1830228-A1 COMPOUND FOR RESIST AND RADIATION-SENSITIVE COMPOSITION MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2007-09-05 EP disclosed
US-3948861-A Polyamide-imides from bis-imide and dialdoxime RHONE-POULENC S.A. (FR) 1976-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110165516-A1 COMPOUND FOR RESIST AND RADIATION-SENSITIVE COMPOSITION XRCC6, XRCC5, KISS1R CYP2A6 3729/4885HSD17B10 1398/4885ALDH5A1 3804/4885
US-20260028317-A1 EFFICIENT PROCEDURE FOR THE SYNTHESIS OF HYDRAZONE-LINKED TETRAHEDRAL NANOCAGES FTH1, AOC2, CCRL2 CYP2A6 942/4885HSD17B10 71/4885ALDH5A1 1813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.